Introduction to the Special Section: Myelin and oligodendrocyte abnormalities in schizophrenia

International Journal of Neuropsychopharmacology

Volumn 10, Issue 4, 2007, Pages 499-502

  Haroutunian, Vahram ^a,b   Davis, Kenneth L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene expression; Microarray; Neuroanatomy; Neuropathology; Post mortem; Schizophrenia

Indexed keywords

MYELIN;

BRAIN TISSUE; CADAVER; CELL COUNT; CELL FUNCTION; CELL ULTRASTRUCTURE; GENE EXPRESSION; HUMAN; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; NEUROANATOMY; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MYELIN SHEATH; NERVE TISSUE PROTEINS; NEUROANATOMY; NEUROBIOLOGY; OLIGODENDROGLIA; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SIGNAL TRANSDUCTION;

EID: 34250798551     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706007449     Document Type: Review

References (25)

1. Baumann N, Pham-Dinh D (2001). Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiological Reviews 81, 871-927.
2. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof P, Buxbaum JD, Haroutunian V (2003). White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry 60, 443-456.
3. Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V (2006). Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in schizophrenia. Neurobiology of Disease 79, 157-173.
4. Dwork AJ, Mancevski B, Rosoklija G (2007). White matter and cognitive function in schizophrenia. International Journal of Neuropsychopharmacology. Published online: 21 February 2007. doi: 10.1017/S1461145707007638.
5. Flynn SW, Lang DJ, MacKay AL, Goghari V, Vavasour IM, Whittall KP, Smith GN, Arango V, Mann JJ, Dwork AJ, et al. (2003). Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Molecular Psychiatry 8, 811-820.
6. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences USA 98, 4746-4751.
7. Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL (2007). Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. International Journal of Neuropsychopharmacology. Published online: 12 February 2007. doi: 10.1017/S1461145706007310.
8. Harrison PJ, Weinberger DR (2004). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 10, 40-68.
9. Haydon PG (2001). GLIA: listening and talking to the synapse. Nature Reviews Neuroscience 2, 185-193.
10. Hof PR, Haroutunian V, Friedrich Jr. VL, Byne W, Buitron C, Perl DP, Davis KL (2003). Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biological Psychiatry 53, 1075-1085.
11. Katsel P, Davis KL, Haroutunian V (2004). Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. International Review of Neurobiology 63, 41-81.
12. Larocca JN, Rodriguez-Gabin AG (2002). Myelin biogenesis: vesicle transport in oligodendrocytes. Neurochemical Research 27, 1313-1329.
13. Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA (2006). Making the case for a candidate vulnerability gene in schizophrenia: convergent evidence for regulator of G-protein signaling 4 (RGS4). Biological Psychiatry 60, 534-537.
14. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P (2002). Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. Journal of Neuroscience 22, 2718-2729.
15. Mirnics K, Middleton FA, Lewis DA, Levitt P (2001). Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends in Neuroscience 24, 479-86.
16. Orlovskaia DD, Vostrikov V, Rachmanova V, Uranova NA (2000). Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder and major depression. Schizophrenia Research 41, 105-106.
17. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JJ, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, et al. (2004). Mitochondrial dysfunction in Schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry 9, 684-697.
18. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, Hays AP, Dwork AJ (2000). Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Archives of General Psychiatry 57, 349-356.
19. Segal D, Koschnick JR, Slegers LHA, Hof PR (2007). Oligodendrocyte pathophysiology: a new view of schizophrenia. International Journal of Neuropsychopharmacology. Published online: 12 February 2007. doi: 10.1017/S146114570600722X.
20. Sokolov BP (2007). Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies? International Journal of Neuropsychopharmacology. Published online: 12 February 2007. doi: 10.1017/S1461145706007322.
21. Stewart DG, Davis KL (2004). Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. International Review of Neurobiology 59, 381-424.
22. Tkachev D, Mimmack ML, Huffaker SJ, Ryan M, Bahn S (2007). Futher evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. International Journal of Neuropsychopharmacology. Published online: 12 February 2007. doi: 10.1017/S1461145706007334.
23. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research 67, 269-275.
24. Uranova NA, Vostrikov VM, Vichreva OV, Zimina IS, Kolomeets NS, Orlovskaya DD (2007). The role of oligodendrocyte pathology in schizophrenia. International Journal of Neuropsychopharmacology. Published online: 21 February 2007. doi: 10.1017/S1461145707007626.
25. Wright IC, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157, 16-25.